 Shares of ProKidney Corp. PROK rallied about 29 in premarket trading on Wednesday, the day after the company said preliminary data from a Phase 2 study found that the companys investigational renal autologous cell therapy treatment can delay the need for dialysis in some patients with chronic kidney disease. The study was published Jan. 4 ... The post : ProKidneys stock jumps 29 appeared first on ForexTV... 